Aptevo Therapeutics Inc (APVO) has fallen Wednesday morning, with the stock declining -16.50% in pre-market trading to 14.22. APVO's short-term technical score of 65 indicates that the stock has traded more bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, the stock ranks higher than 92% of stocks. Aptevo Therapeutics Inc has risen 19.51% over the past month, closing at $14.60 on October 27. During this period of time, the stock fell as low as $6.48 and as high as $22.08. APVO has an average analyst recommendation of Strong Buy. The company has an average price target of $52.50.
APVO has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on APVO!